An investigation of changes in regional gray matter volume in cardiovascular disease patients, pre and post cardiovascular rehabilitation

U C Anazodo, J K Shoemaker, N Suskin, K S St Lawrence, U C Anazodo, J K Shoemaker, N Suskin, K S St Lawrence

Abstract

Cognitive function decline secondary to cardiovascular disease has been reported. However, little is known about the impact of coronary artery disease (CAD) on the aging brain macrostructure or whether exercise training, in the context of cardiovascular rehabilitation, can affect brain structure following a coronary event. This study employed voxel-based morphometry of high resolution structural MRI images to investigate; 1) changes in regional gray matter volume (GMV) in CAD patients compared to age-matched controls, and 2) the effects of a six-month exercise-based cardiovascular rehabilitation program on CAD-related GMV decline. Compared to controls, significant decreases in regional GMV were found in the superior, medial and inferior frontal gyrus; superior and inferior parietal gyrus; middle and superior temporal gyrus and in the posterior cerebellum of CAD patients. Cardiovascular rehabilitation was associated with the recovery of regional GMV in the superior frontal gyrus, superior temporal gyrus and posterior cerebellum of the CAD patients as well as the increase in GMV in the supplementary motor area. Total and regional GMV correlated with fitness level, defined by the maximal oxygen consumption (VO2max), at baseline but not after cardiovascular rehabilitation. This study demonstrates that cardiovascular disease can adversely affect age-related decline in GMV; and that these disease-related effects could be mitigated by moderate levels of exercise training as part of cardiovascular rehabilitation.

Keywords: CAD, Coronary artery disease; CR, Cardiovascular rehabilitation; Coronary artery disease; Exercise training; GMV, gray matter volume; METs, metabolic equivalents; MoCA, Montreal Cognitive Assessment; Neuroplasticity; Regional brain atrophy; VBM, voxel-based morphometry; VO2max, maximal oxygen consumption; Voxel-based morphometry.

Figures

Fig. 1
Fig. 1
Differences in GMV between CAD patients and age-matched controls measured at baseline. t-Statistics displayed on a rendered model of a single subject brain. The red blobs on coronal, sagittal and transverse planes indicate areas of decreased GMV in the CAD patient group.
Fig. 2
Fig. 2
GMV changes over time in CAD patient pre and post CR. t-Static displayed on a rendered model of a single subject brain. Red blobs on coronal, sagittal and transverse planes indicate areas of increased GMV in the CAD group after 6 months of CR.

References

    1. ACSM . 5th ed. Lippincott Williams and Wilkins; Philadelphia, Pa: 1995. Guidelines for Exercise Testing and Prescription; p. 160.
    1. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage. 2007;38:95–113.
    1. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. NeuroImage. 2000;11:805–821.
    1. Ashburner J., Ridgway G.R. Symmetric diffeomorphic modeling of longitudinal structural MRI. Front. Neurosci. 2013;(5,6):197. (Feb)
    1. Baker L.D., Frank L.L., Foster-Schubert K., Green P.S. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch. Neurol. 2010;67:71–79.
    1. Barnes D.E., Yaffe K., Satariano W.A., Tager I.B. A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults. J. Am. Geriatr. Soc. 2003;51:459–464.
    1. Borg G.A. Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc. 1982;14:377–381.
    1. Chilton R.J. Pathophysiology of coronary heart disease: a brief review. J. Am. Osteopath. Assoc. 2004;104:S5–S8.
    1. Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B., Emberson J., Blackwell L. The effects of lowering LDL cholesterol with statin therapy in people with low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581–590.
    1. Christensen H., Batterham P.J., Mackinnon A.J., Anstey K.J., Wen W., Sachdev P.S. Education, atrophy and cognitive change in an epidemiological sample in early old age. Am. J. Geriatr. Psychiatry. 2009;17(3):218–226.
    1. Colcombe S.J., Kramer A.F., Erickson K.I., Scalf P., McAuley E., Cohen N.J., Webb A., Jerome G.J., Marquez D.X., Elavsky S. Cardiovascular fitness, cortical plasticity, and aging. Proc. Natl. Acad. Sci. U. S. A. 2004;101:3316–3321.
    1. Colcombe S.J., Erickson K.I., Scalf P.E., Kim J.S., Prakash R., Mcauley E., Elavsky S., Marquez D.X., Hu L., Kramer A.F. Aerobic exercise training increases brain volume in aging humans. J. Geronotol. 2006;61:1166–1170.
    1. Dai W., Lopez O.L., Carmichael O.T., Becker J.T., Kuller L.H., Gach H.M. Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke. 2008;39:349–354.
    1. De la Torre J. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis. Neurobiol. Aging. 2000;21:331–342.
    1. De Toledo Ferraz Alves T.C., Ferreira L.K., Wajngarten M., Busatto G.F. Cardiac disorders as risk factors for Alzheimer's disease. J. Alzheimers Dis. 2010;20:749–763.
    1. Erickson K.I., Raji C.A., Lopez O.L., Becker J.T., Rosano C., Newman A.B., Gach H.M., Thompson P.M., Ho A.J., Kuller L.H. Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology. 2010;75:1415–1422.
    1. Erickson K.I., Miller D.L., Weinstein A.M., Akl S.L., Banducci S. Physical activity and brain plasticity in late adulthood: a conceptual and comprehensive review. Ageing Res. 2012;4:e6.
    1. Fletcher G.F., Balady G.J., Amsterdam E.A., Chaitman B., Eckel R., Fleg J. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation. 2001;104:1694–1740.
    1. Fujiwara Y., Chaves P.H., Takahashi R. Arterial pulse wave velocity as a marker of poor cognitive function in elderly community-dwelling population. J. Geronot. A Biol. Sci. Med. Sci. 2005;60:607–612.
    1. Genovese C.R., Lazar N.A., Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage. 2002;15:870–878.
    1. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage. 2001;14:21–36.
    1. Greene S.J., Killiany R.J., ADNI Subregions of the inferior parietal lobule are affected in the progression to AD. Neurobiol. Aging. 2010;31:1304–1311.
    1. Hedden T., Gabrieli J.D. Insights into the aging mind: a view from cognitive neuroscience. Nat. Rev. Neurosci. 2004;5:87–96.
    1. IOM (Institute of Medicine) The National Academic Press; Washington, DC: 2010. Promoting Cardiovascular Health in Developing World: A Critical Challenge to Achieve Global Health.
    1. Jefferson A.L. Cardiac output as a potential risk factor for abnormal brain aging. J. Alzheimers Dis. 2010;20:813–821.
    1. Jefferson A.L., Poppas A., Paul R.H., Cohen R.A. Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol. Aging. 2007;28:477–483.
    1. Jefferson A.L., Tate D.F., Poppas A., Brickman A.M., Paul R.H., Gunstand J., Cohen R.A. Lower cardiac output is associated with greater white matter hyperintensities in older adults with cardiovascular disease. J. Am. Geriatr. Soc. 2007;55:1044–1048.
    1. Karvonen M., Kentala K., Mustala O. The effects of training on heart rate: longitudinal study. Ann. Med. Exp. Biol. Fenn. 1957;35:307–315.
    1. Koschack J., Irle E. Small hippocampal size in cognitively normal subjects with coronary artery disease. Neurobiol. Aging. 2005;26:865–871.
    1. Larson E.B., Wang L., Bowen J.D., McCormick W.C., Teri L., Crane P. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med. 2006;144:73–81.
    1. Last D., Alsop D., Abduljalil A., Marquis R., De Bazelaire C., Hu K., Cavallerano J., Novak V. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivty. Diabetes Care. 2007;30:1193–1199.
    1. Lautenschlager N.T., Cox K.L., Flicker L., Foster J.K., van Bockxmeer F.M., Xiao J., Greenop K.R., Almedia O.P. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA. 2008;300:1027–1037.
    1. Lavie C.J., Thomas R.J., Squires R.W., Allison T.G., Milani R.V. Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin. Proc. 2009;84:373–383.
    1. McAuley E., Kramer A.F., Colcombe S.J. Cardiovascular fitness and neurocognitive function in older Adults: a brief review. Brain Behav. Immun. 2004;18:214–220.
    1. Muller M., Grobbee D.E., Aleman A., Bots M., Van der Schouw Y.T. Cardiovascular disease and cognitive performance in middle-aged and elderly men. Atherosclerosis. 2007;190:143–149.
    1. Nasreddine Z., Phillips N., Bedirian V., Charbonneau S., Whitehead V., Collin I., Cummings J., Cherktow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53:695–699.
    1. Nordlund A., Rolstad S., Klang O., Lind K., Hansen S., Wallin A. Cognitive profiles of mild cognitive impairment with and without vascular disease. Neuropsychology. 2007;21:706–712.
    1. Okonkwo O.C., Cohen R.A., Gunstad J., Tremont G., Alosco M.L., Poppas A. Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease. Cerebrovasc. Dis. 2010;30:362–373.
    1. Pflieger M., Winslow B.T., Mills K., Dauber I.M. Medical management of stable coronary artery disease. Am. Fam. Physician. 2011;83(7):819–826.
    1. Powell K.E., Thompson P.D., Caspersen C.J., Kendrick J.S. Physical activity and the incidence of coronary heart disease. Annu. Rev. Public Health. 1987;8:235–287.
    1. Selnes O.A., McKhann G.M. Neurocognitive complications after coronary artery bypass surgery. Ann. Neurol. 2005;57:615–621.
    1. Shephard R.J., Balady G.J. Exercise as cardiovascular therapy. Circulation. 1999;99:963–972.
    1. Smith S.C., Benjamin E.J., Bonow R.O., Braun L.T. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124:2458–2473.
    1. Stone J., Arthur H., Suskin N. 3rd ed. Canadian Association for Cardiac Rehabilitation; Winipeg, MB: 2009. Guidelines for Cardiac Rehabilitation and Cardiovascular Disease Prevention: Translating Knowledge into Action.
    1. Wendell C.R., Zonderman A.B., Metter E.J., Najjar S.S., Waldstein S.R. Carotid Intima medial thickness predicts cognitive decline among adults with and without clinical vascular disease. Stroke. 2009;40:3180–3185.
    1. World Health Organization (WHO) Global Atlas on Cardiovascular Disease Prevention and Control. In: Mendis S., Puska P., Norrving B., editors. World Health Organization; Geneva: 2011.
    1. Yoon C.W., Seo S.W., Park J.S., Kwak K.C. Cerebellar atrophy in patients with subcortical-type vascular cognitive impairment. Cerebellum. 2013;12:35–42.
    1. Yuki A., Lee S., Kim H., Kozakai R. Relationship between physical activity and brain atrophy progression. Med. Sci. Sports Exerc. 2012;44:2362–2368.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa